Raymond James Financial Inc. purchased a new position in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 106,687 shares of the specialty chemicals company's stock, valued at approximately $13,087,000. Raymond James Financial Inc. owned about 0.51% of Hawkins as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the company. Larson Financial Group LLC lifted its stake in shares of Hawkins by 8,633.3% in the 3rd quarter. Larson Financial Group LLC now owns 262 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 259 shares during the last quarter. Blue Trust Inc. raised its position in Hawkins by 155.4% during the 4th quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company's stock valued at $44,000 after purchasing an additional 216 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Hawkins by 262.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 442 shares of the specialty chemicals company's stock valued at $55,000 after purchasing an additional 320 shares during the last quarter. TD Private Client Wealth LLC raised its position in Hawkins by 242.5% during the 3rd quarter. TD Private Client Wealth LLC now owns 459 shares of the specialty chemicals company's stock valued at $59,000 after purchasing an additional 325 shares during the last quarter. Finally, KBC Group NV raised its position in Hawkins by 37.0% during the 4th quarter. KBC Group NV now owns 948 shares of the specialty chemicals company's stock valued at $116,000 after purchasing an additional 256 shares during the last quarter. Institutional investors own 69.71% of the company's stock.
Hawkins Trading Up 0.7 %
HWKN traded up $0.76 during midday trading on Friday, reaching $105.77. 367,892 shares of the company's stock traded hands, compared to its average volume of 121,037. The firm has a fifty day moving average of $109.41 and a two-hundred day moving average of $119.05. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 3.80 and a beta of 0.77. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. Hawkins, Inc. has a 52 week low of $71.98 and a 52 week high of $139.55.
Hawkins (NASDAQ:HWKN - Get Free Report) last posted its earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing analysts' consensus estimates of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. On average, equities analysts anticipate that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.
Hawkins Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.18 per share. The ex-dividend date was Friday, February 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.68%. Hawkins's dividend payout ratio (DPR) is 18.37%.
Analysts Set New Price Targets
Separately, BWS Financial reaffirmed a "neutral" rating and set a $122.00 price target on shares of Hawkins in a research report on Friday, January 31st.
Get Our Latest Research Report on Hawkins
Hawkins Company Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Featured Stories

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.